Insider: Burnett Patrick See Remarks - Arcutis Biotherapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 104,811 | 0 | 104,811 |
| Value | $1,839,433.05 | $0.00 | $1,839,433.05 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 08/21/2025 | DDS | 2,438 | Direct | COM | $15.57 | $37,968.92 | 104,811 |
| 08/19/2025 | DDS | 1,750 | Direct | COM | $16.16 | $28,280.70 | 107,249 |
| 08/08/2025 | DDS | 3,847 | Direct | COM | $14.03 | $53,988.41 | 108,999 |
| 08/04/2025 | DDS | 2,622 | Direct | COM | $14.33 | $37,564.35 | 112,846 |
| 07/14/2025 | DDS | 5,750 | Direct | COM | $15.07 | $86,653.65 | 115,468 |
| 07/10/2025 | DDS | 23,000 | Direct | COM | $15.05 | $346,046.50 | 115,468 |
| 05/08/2025 | DDS | 3,871 | Direct | COM | $13.59 | $52,623.15 | 115,468 |
| 05/02/2025 | DDS | 2,597 | Direct | COM | $15.19 | $39,442.46 | 119,339 |
| 03/14/2025 | DDS | 12,242 | Direct | COM | $15.04 | $184,107.44 | 121,936 |
| 03/13/2025 | DDS | 44,153 | Direct | COM | $14.97 | $660,771.72 | 121,936 |
| 03/13/2025 | DDS | 5,008 | Direct | COM | $15.10 | $75,631.32 | 121,936 |
| 03/04/2025 | DDS | 954 | Direct | COM | $13.28 | $12,673.03 | 166,089 |
| 03/03/2025 | DDS | 2,819 | Direct | COM | $13.03 | $36,734.67 | 167,043 |
| 02/03/2025 | DDS | 12,116 | Direct | COM | $12.70 | $153,873.20 | 114,862 |
| 12/31/2024 | DDS | 1,691 | Direct | COM | $14.00 | $23,674.00 | 126,978 |
| 11/22/2024 | DDS | 16,023 | Direct | COM | $10.14 | $162,514.88 | 128,669 |
| 11/15/2024 | DDS | 100 | Direct | COM | $10.03 | $1,003.00 | 128,669 |
| 11/14/2024 | DDS | 18,377 | Direct | COM | $10.29 | $189,182.03 | 128,669 |
| 11/14/2024 | DDS | 50,749 | Direct | COM | $10.29 | $522,435.58 | 128,669 |
| 11/04/2024 | DDS | 15,441 | Direct | COM | $8.68 | $134,092.73 | 179,418 |
| 08/19/2024 | DDS | 1,728 | Direct | COM | $8.29 | $14,318.21 | 194,859 |
| 08/02/2024 | DDS | 13,206 | Direct | COM | $9.02 | $119,106.23 | 196,587 |
| 05/30/2024 | DDS | 23,000 | Direct | COM | $8.75 | $201,319.00 | 209,793 |
| 05/29/2024 | DDS | 49,952 | Direct | COM | $8.72 | $435,386.63 | 209,793 |
| 05/02/2024 | DDS | 9,555 | Direct | COM | $8.74 | $83,489.68 | 259,745 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research